Literature DB >> 7579778

P-glycoprotein expression and regulation. Age-related changes and potential effects on drug therapy.

S Gupta1.   

Abstract

P-Glycoprotein is a member of a superfamily of adenosine triphosphate-binding cassette transporter proteins and plays an important role in multidrug resistance in cancer cells. P-Glycoprotein is known to transport a wide variety of substances ranging from ions to peptides. P-Glycoprotein is expressed on a variety of normal cells, however its physiological function is unclear. The apical and polar distribution on secretory cells suggests a secretory role for P-glycoprotein. More recently, cells of the immune system have been shown to express P-glycoprotein. There is evidence to suggest that P-glycoprotein may play a role in the secretion of certain cytokines (especially those lacking signal sequence) and cytotoxic molecules. In this article, the basic structure, gene regulation and expression of P-glycoprotein are reviewed. Furthermore, age-related changes in the expression of P-glycoprotein and potential effects on drug therapy in the elderly are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7579778     DOI: 10.2165/00002512-199507010-00003

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  78 in total

1.  Peptide transport by the multidrug resistance pump.

Authors:  R C Sharma; S Inoue; J Roitelman; R T Schimke; R D Simoni
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

2.  Structure and expression of the human MDR (P-glycoprotein) gene family.

Authors:  J E Chin; R Soffir; K E Noonan; K Choi; I B Roninson
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

Review 3.  Resistance of multidrug-resistant lines to natural killer-like cell-mediated cytotoxicity.

Authors:  G Woods; L A Lund; M Naik; V Ling; A Ochi
Journal:  FASEB J       Date:  1988-09       Impact factor: 5.191

4.  Study of membrane orientation and glycosylated extracellular loops of mouse P-glycoprotein by in vitro translation.

Authors:  J T Zhang; V Ling
Journal:  J Biol Chem       Date:  1991-09-25       Impact factor: 5.157

5.  Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells.

Authors:  A Kimmig; V Gekeler; M Neumann; G Frese; R Handgretinger; G Kardos; H Diddens; D Niethammer
Journal:  Cancer Res       Date:  1990-11-01       Impact factor: 12.701

6.  Flow cytometric analysis of P-glycoprotein in normal and leukemic cells.

Authors:  M I Tiirikainen; M T Syrjälä; S E Jansson; T Krusius
Journal:  Ann Hematol       Date:  1992-09       Impact factor: 3.673

7.  Characterization of the azidopine and vinblastine binding site of P-glycoprotein.

Authors:  E P Bruggemann; S J Currier; M M Gottesman; I Pastan
Journal:  J Biol Chem       Date:  1992-10-15       Impact factor: 5.157

8.  Modulation of drug permeability in Chinese hamster ovary cells. Possible role for phosphorylation of surface glycoproteins.

Authors:  S V Carlsen; J E Till; V Ling
Journal:  Biochim Biophys Acta       Date:  1977-06-02

9.  Age-related changes in human lymphocyte subsets: progressive reduction of the CD4 CD45R (suppressor inducer) population.

Authors:  P De Paoli; S Battistin; G F Santini
Journal:  Clin Immunol Immunopathol       Date:  1988-09

10.  The multidrug resistance (mdr1) gene product functions as an ATP channel.

Authors:  E H Abraham; A G Prat; L Gerweck; T Seneveratne; R J Arceci; R Kramer; G Guidotti; H F Cantiello
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

View more
  13 in total

Review 1.  Drug metabolism and ageing.

Authors:  M T Kinirons; M S O'Mahony
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

2.  In vivo specific binding characteristics and pharmacokinetics of a 1,4-dihydropyridine calcium channel antagonist in the senescent mouse brain.

Authors:  S Uchida; S Yamada; Y Deguchi; M Yamamoto; R Kimura
Journal:  Pharm Res       Date:  2000-07       Impact factor: 4.200

3.  Serum Concentrations and Elimination Rates of Direct-Acting Oral Anticoagulants (DOACs) in Older Hip Fracture Patients Hospitalized for Surgery: A Pilot Study.

Authors:  Kirsten K Viktil; Ina Lehre; Anette H Ranhoff; Espen Molden
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

4.  Altered expression and function of P-glycoprotein (170 kDa), encoded by the MDR 1 gene, in T cell subsets from aging humans.

Authors:  S Aggarwal; T Tsuruo; S Gupta
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

5.  Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

Authors:  S M Clee; J J Kastelein; M van Dam; M Marcil; K Roomp; K Y Zwarts; J A Collins; R Roelants; N Tamasawa; T Stulc; T Suda; R Ceska; B Boucher; C Rondeau; C DeSouich; A Brooks-Wilson; H O Molhuizen; J Frohlich; J Genest; M R Hayden
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

6.  Clinical Experience with Extended-Release Tacrolimus in Older Adult Kidney Transplant Recipients: A Retrospective Cohort Study.

Authors:  Spenser E January; Jennifer C Hagopian; Nicole M Nesselhauf; Kristin Progar; Timothy A Horwedel; Rowena Delos Santos
Journal:  Drugs Aging       Date:  2021-03-23       Impact factor: 3.923

Review 7.  Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

8.  P-glycoprotein function in the elderly.

Authors:  Stefanie S Brenner; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2004-03-12       Impact factor: 2.953

Review 9.  Mechanisms of clinically relevant drug interactions associated with tacrolimus.

Authors:  Uwe Christians; Wolfgang Jacobsen; Leslie Z Benet; Alfonso Lampen
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 10.  Cyclosporin pharmacokinetics in the elderly.

Authors:  J M Kovarik; E U Koelle
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 4.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.